(WD) Walker & Dunlop - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US93148P1021
Stock: Real Estate Finance, Loan Origination, Loan Servicing, Debt Brokerage, Advisory Services
Total Rating 13
Risk 74
Buy Signal -1.34
| Risk 5d forecast | |
|---|---|
| Volatility | 51.3% |
| Relative Tail Risk | -13.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.21 |
| Alpha | -56.81 |
| Character TTM | |
|---|---|
| Beta | 0.924 |
| Beta Downside | 0.683 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.74% |
| CAGR/Max DD | -0.22 |
EPS (Earnings per Share)
Revenue
Description: WD Walker & Dunlop March 04, 2026
Walker & Dunlop, Inc. (WD) is a commercial real estate finance company operating in the United States. It originates, sells, and services various financing products for real estate owners and developers.
The companys business model spans three segments: Capital Markets, Servicing & Asset Management, and Corporate. Capital Markets involves loan origination and brokerage, connecting borrowers with institutional lenders. Servicing & Asset Management focuses on managing loan portfolios and third-party capital, including investments in the Low-Income Housing Tax Credit (LIHTC) sector. Real estate finance is a cyclical industry, sensitive to interest rate changes and economic conditions.
WD offers a diverse range of loan products, including first mortgage, construction, and mezzanine loans. It finances various property types such as multifamily, student housing, and affordable housing, often leveraging programs like Fannie Maes DUS. The company also provides property sales brokerage, appraisal, and investment banking services.
For a deeper analysis of WDs financial performance and market position, consider exploring its profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 57.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.13 > 0.02 and ΔFCF/TA -16.10 > 1.0 |
| NWC/Revenue: -124.0% < 20% (prev 150.9%; Δ -274.9% < -1%) |
| CFO/TA -0.13 > 3% & CFO -664.3m > Net Income 57.0m |
| Net Debt (1.95b) to EBITDA (350.0m): 5.57 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.4m) vs 12m ago 0.44% < -2% |
| Gross Margin: 58.50% > 18% (prev 0.44%; Δ 5806 % > 0.5%) |
| Asset Turnover: 26.15% > 50% (prev 25.84%; Δ 0.30% > 0%) |
| Interest Coverage Ratio: 2.66 > 6 (EBITDA TTM 350.0m / Interest Expense TTM 41.9m) |
Altman Z'' -0.59
| A: -0.30 (Total Current Assets 718.7m - Total Current Liabilities 2.25b) / Total Assets 5.06b |
| B: 0.25 (Retained Earnings 1.28b / Total Assets 5.06b) |
| C: 0.02 (EBIT TTM 111.3m / Avg Total Assets 4.72b) |
| D: 0.39 (Book Value of Equity 1.28b / Total Liabilities 3.31b) |
| Altman-Z'' Score: -0.59 = B |
Beneish M
| DSRI: 0.33 (Receivables 419.4m/1.15b, Revenue 1.23b/1.13b) |
| GMI: 0.76 (GM 58.50% / 44.46%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.09 (Revenue 1.23b / 1.13b) |
| TATA: 0.14 (NI 57.0m - CFO -664.3m) / TA 5.06b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of WD shares?
As of March 07, 2026, the stock is trading at USD 48.19 with a total of 403,483 shares traded.
Over the past week, the price has changed by +4.74%, over one month by -23.79%, over three months by -23.40% and over the past year by -42.38%.
Over the past week, the price has changed by +4.74%, over one month by -23.79%, over three months by -23.40% and over the past year by -42.38%.
Is WD a buy, sell or hold?
Walker & Dunlop has received a consensus analysts rating of 3.40.
Therefor, it is recommend to hold WD.
- StrongBuy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65 | 34.9% |
| Analysts Target Price | 65 | 34.9% |
WD Fundamental Data Overview March 05, 2026
P/E Trailing = 14.451
P/E Forward = 10.989
P/S = 1.4303
P/B = 0.9191
P/EG = 1.25
Revenue TTM = 1.23b USD
EBIT TTM = 111.3m USD
EBITDA TTM = 350.0m USD
Long Term Debt = 3.01b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.25b USD (from shortTermDebt, last quarter)
Debt = 2.25b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.95b USD (from netDebt column, last quarter)
Enterprise Value = 3.61b USD (1.66b + Debt 2.25b - CCE 299.3m)
Interest Coverage Ratio = 2.66 (Ebit TTM 111.3m / Interest Expense TTM 41.9m)
EV/FCF = -5.31x (Enterprise Value 3.61b / FCF TTM -680.1m)
FCF Yield = -18.84% (FCF TTM -680.1m / Enterprise Value 3.61b)
FCF Margin = -55.10% (FCF TTM -680.1m / Revenue TTM 1.23b)
Net Margin = 4.62% (Net Income TTM 57.0m / Revenue TTM 1.23b)
Gross Margin = 58.50% ((Revenue TTM 1.23b - Cost of Revenue TTM 512.2m) / Revenue TTM)
Gross Margin QoQ = 63.48% (prev 42.59%)
Tobins Q-Ratio = 0.71 (Enterprise Value 3.61b / Total Assets 5.06b)
Interest Expense / Debt = 0.97% (Interest Expense 21.8m / Debt 2.25b)
Taxrate = 27.87% (22.0m / 79.0m)
NOPAT = 80.3m (EBIT 111.3m * (1 - 27.87%))
Current Ratio = 0.32 (Total Current Assets 718.7m / Total Current Liabilities 2.25b)
Debt / Equity = 1.30 (Debt 2.25b / totalStockholderEquity, last quarter 1.74b)
Debt / EBITDA = 5.57 (Net Debt 1.95b / EBITDA 350.0m)
Debt / FCF = -2.87 (negative FCF - burning cash) (Net Debt 1.95b / FCF TTM -680.1m)
Total Stockholder Equity = 1.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.21% (Net Income 57.0m / Total Assets 5.06b)
RoE = 3.26% (Net Income TTM 57.0m / Total Stockholder Equity 1.75b)
RoCE = 2.34% (EBIT 111.3m / Capital Employed (Equity 1.75b + L.T.Debt 3.01b))
RoIC = 2.01% (NOPAT 80.3m / Invested Capital 4.00b)
WACC = 4.36% (E(1.66b)/V(3.91b) * Re(9.32%) + D(2.25b)/V(3.91b) * Rd(0.97%) * (1-Tc(0.28)))
Discount Rate = 9.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.65%
[DCF] Fair Price = unknown (Cash Flow -680.1m)
EPS Correlation: -48.74 | EPS CAGR: -41.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 10.22 | Revenue CAGR: 1.68% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.32 | Chg7d=-0.063 | Chg30d=-0.063 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=5.06 | Chg7d=-0.371 | Chg30d=+0.049 | Revisions Net=+1 | Growth EPS=+44.5% | Growth Revenue=+11.2%
EPS next Year (2027-12-31): EPS=5.92 | Chg7d=-0.027 | Chg30d=+0.507 | Revisions Net=+1 | Growth EPS=+17.1% | Growth Revenue=+9.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 9.3% - Earnings Yield 6.9%)
[Growth] Growth Spread = +7.4% (Analyst 9.8% - Implied 2.4%)
P/E Forward = 10.989
P/S = 1.4303
P/B = 0.9191
P/EG = 1.25
Revenue TTM = 1.23b USD
EBIT TTM = 111.3m USD
EBITDA TTM = 350.0m USD
Long Term Debt = 3.01b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.25b USD (from shortTermDebt, last quarter)
Debt = 2.25b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.95b USD (from netDebt column, last quarter)
Enterprise Value = 3.61b USD (1.66b + Debt 2.25b - CCE 299.3m)
Interest Coverage Ratio = 2.66 (Ebit TTM 111.3m / Interest Expense TTM 41.9m)
EV/FCF = -5.31x (Enterprise Value 3.61b / FCF TTM -680.1m)
FCF Yield = -18.84% (FCF TTM -680.1m / Enterprise Value 3.61b)
FCF Margin = -55.10% (FCF TTM -680.1m / Revenue TTM 1.23b)
Net Margin = 4.62% (Net Income TTM 57.0m / Revenue TTM 1.23b)
Gross Margin = 58.50% ((Revenue TTM 1.23b - Cost of Revenue TTM 512.2m) / Revenue TTM)
Gross Margin QoQ = 63.48% (prev 42.59%)
Tobins Q-Ratio = 0.71 (Enterprise Value 3.61b / Total Assets 5.06b)
Interest Expense / Debt = 0.97% (Interest Expense 21.8m / Debt 2.25b)
Taxrate = 27.87% (22.0m / 79.0m)
NOPAT = 80.3m (EBIT 111.3m * (1 - 27.87%))
Current Ratio = 0.32 (Total Current Assets 718.7m / Total Current Liabilities 2.25b)
Debt / Equity = 1.30 (Debt 2.25b / totalStockholderEquity, last quarter 1.74b)
Debt / EBITDA = 5.57 (Net Debt 1.95b / EBITDA 350.0m)
Debt / FCF = -2.87 (negative FCF - burning cash) (Net Debt 1.95b / FCF TTM -680.1m)
Total Stockholder Equity = 1.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.21% (Net Income 57.0m / Total Assets 5.06b)
RoE = 3.26% (Net Income TTM 57.0m / Total Stockholder Equity 1.75b)
RoCE = 2.34% (EBIT 111.3m / Capital Employed (Equity 1.75b + L.T.Debt 3.01b))
RoIC = 2.01% (NOPAT 80.3m / Invested Capital 4.00b)
WACC = 4.36% (E(1.66b)/V(3.91b) * Re(9.32%) + D(2.25b)/V(3.91b) * Rd(0.97%) * (1-Tc(0.28)))
Discount Rate = 9.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.65%
[DCF] Fair Price = unknown (Cash Flow -680.1m)
EPS Correlation: -48.74 | EPS CAGR: -41.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 10.22 | Revenue CAGR: 1.68% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.32 | Chg7d=-0.063 | Chg30d=-0.063 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=5.06 | Chg7d=-0.371 | Chg30d=+0.049 | Revisions Net=+1 | Growth EPS=+44.5% | Growth Revenue=+11.2%
EPS next Year (2027-12-31): EPS=5.92 | Chg7d=-0.027 | Chg30d=+0.507 | Revisions Net=+1 | Growth EPS=+17.1% | Growth Revenue=+9.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 9.3% - Earnings Yield 6.9%)
[Growth] Growth Spread = +7.4% (Analyst 9.8% - Implied 2.4%)